Talk:Eptifibatide
Jump to navigation
Jump to search
| This is the talk page for discussing improvements to the Eptifibatide article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Eptifibatide.
|
Structural diagram
I noticed that the diagram incorrectly depicts the L-proline residue as a D-proline residue. Can someone correct this? — Preceding unsigned comment added by 108.6.30.37 (talk) 23:14, 16 March 2020 (UTC)